Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Abeona Therapeutics (ABEO) Return on Sales (2016 - 2025)

Abeona Therapeutics (ABEO) has 15 years of Return on Sales data on record, last reported at 244.46% in Q3 2025.

  • For Q3 2025, Return on Sales changed N/A year-over-year to 244.46%; the TTM value through Sep 2025 reached 244.46%, changed N/A, while the annual FY2023 figure was 13.59%, 2294.0% up from the prior year.
  • Return on Sales reached 244.46% in Q3 2025 per ABEO's latest filing, down from 59.37% in the prior quarter.
  • Across five years, Return on Sales topped out at 880.55% in Q4 2021 and bottomed at 244.46% in Q3 2025.
  • Average Return on Sales over 5 years is 13.95%, with a median of 13.59% recorded in 2023.
  • Peak YoY movement for Return on Sales: surged 88791bps in 2021, then crashed -107340bps in 2022.
  • A 5-year view of Return on Sales shows it stood at 880.55% in 2021, then plummeted by -122bps to 192.85% in 2022, then surged by 93bps to 13.59% in 2023, then dropped by -7bps to 14.48% in 2024, then crashed by -1588bps to 244.46% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Sales were 244.46% in Q3 2025, 59.37% in Q2 2025, and 14.48% in Q1 2024.